Zynext Ventures Invests in Agenus to Enhance Global Immuno-Oncology Portfolio Zynext Ventures has invested in Agenus Inc., boosting its immuno-oncology pipeline and supporting innovation in cancer therapies. This collaboration aims to accelerate treatment development for high-unmet need cancers.

Zynext Ventures Invests in Agenus to Enhance Global Immuno-Oncology Portfolio #United_States #Immuno-Oncology #Zynext_Ventures #Agenus #Pennington,_New_Jersey

Zynext Ventures Fuels Feldan Therapeutics' Breakthrough in Drug Delivery Innovations Zynext Ventures announces its investment in Feldan Therapeutics, focusing on pioneering intracellular drug delivery solutions for better patient outcomes.

Zynext Ventures Fuels Feldan Therapeutics' Breakthrough in Drug Delivery Innovations #USA #Zydus_Lifesciences #Zynext_Ventures #Pennington #Feldan_Therapeutics

Zynext Ventures Invests in Illexcor Therapeutics to Innovate Sickle Cell Disease Treatments Zynext Ventures has announced a significant investment in Illexcor Therapeutics to advance innovative oral therapies for sickle cell disease, highlighting their commitment to healthcare advancements.

Zynext Ventures Invests in Illexcor Therapeutics to Innovate Sickle Cell Disease Treatments #USA #Sickle_Cell #Zynext_Ventures #Illexcor #Pennington